Report cover image

Pancreatic Cancer Therapeutics and Diagnostic Market, By Type (Treatment (Targeted Therapies, Chemotherapy, Surgery, and Other Treatments), By Geography (North America, Europe, Asia Pacific, Middle East, Africa, and Latin America)

Publisher Coherent Market Insights
Published Jun 09, 2025
Length 170 Pages
SKU # CMI20173436

Description

Pancreatic cancer is cancer that forms in the cells of the pancreas. Pancreatic cancer occurs when changes (mutations) in the pancreas cells lead them to multiply out of control. The cancer can be diagnosed with the help of ultrasound, computerized tomography (CT) scans, magnetic resonance imaging (MRI) and positron emission tomography (PET) scans. Treatment may include surgery, radiation, chemotherapy, or a combination of these.

Market Dynamics:

Rise in incidence and prevalence of pancreatic cancer, rise in development of novel therapeutics, growing geriatric population, increase in demand for safe and effective therapeutics, and increase in awareness among people are major factors expected to augment growth of the global pancreatic cancer therapeutics and diagnostic market.

For instance, in January 2021, Myriad Genetics Inc. and Illumina Inc. collaborated to develop a kit-based version of the myChoice companion diagnostic test for international markets, which can be used to detect pancreatic cancer.

Moreover, in September 2020, the Indian Council of Medical Research (ICMR)-National Institute of Cancer Prevention and Research (NICPR) launched www.cancerindia.org with the theme ‘India against Cancer, a portal that provides information on the leading cancers in India with the major focus on awareness, prevention, and treatment of cancers, including pancreatic cancer.

Key features of the study:
  • This report provides in-depth analysis of the global pancreatic cancer therapeutics and diagnostic market, and provides market size (USD Million) and compound annual growth rate (CAGR %) for the forecast period (2025–2032), considering 2024 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global pancreatic cancer therapeutics and diagnostic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include F Hoffmann-La Roche AG, Merck KgaA, Apexigen Inc., Immunovia AB, Viatris Inc., Amgen Inc., AstraZeneca PLC, Bristol-Myers Squibb, Novartis AG, Pfizer Inc., Myriad Genetics Inc., Canon Medical Systems Corporation, FUJIFILM Holdings Corporation, Boston Scientific Corporation, and Rafael Holdings Inc. (Rafael Pharmaceuticals), among others.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global pancreatic cancer therapeutics and diagnostic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pancreatic cancer therapeutics and diagnostic market.
Detailed Segmentation:
  • Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type:
  • Treatment
  • Diagnostics
  • Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography:
  • North America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa
  • Latin America
  • Company Profiles:
  • F.Hoffmann-La Roche AG
  • Merck KgaA
  • Apexigen Inc.
  • Immunovia AB
  • Viatris Inc.
  • Amgen Inc.
  • AstraZeneca PLC
  • Bristol-Myers Squibb
  • Novartis AG
  • Pfizer Inc.
  • Myriad Genetics Inc.
  • Canon Medical Systems Corporation
  • FUJIFILM Holdings Corporation
  • Boston Scientific Corporation
  • Rafael Holdings Inc. (Rafael Pharmaceuticals)

Table of Contents

170 Pages
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snapshot, By Type
Market Snapshot, By Geography
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Rise in incidence and prevalence of pancreatic cancer
High cost associated with diagnosis and treatments
Increase in demand for safe and effective therapeutics
Impact Analysis
Key Highlights
Regulatory Scenario
Product launch/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
4. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Type, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Treatment
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
Diagnostics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(USD Mn)
5. Global Pancreatic Cancer Therapeutics and Diagnostic Market, By Geography, 2020-2032, (USD Mn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
GCC Country
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(USD Mn)
South Africa
North Africa
Central Africa
6. Competitive Landscape
F. Hoffmann-La Roche AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Merck KgaA
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Apexigen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Immunovia AB
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Viatris Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Amgen Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
AstraZeneca PLC
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bristol-Myers Squibb
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Novartis AG
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Pfizer Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Myriad Genetics Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Canon Medical Systems Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
FUJIFILM Holdings Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Boston Scientific Corporation
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Rafael Holdings Inc. (Rafael Pharmaceuticals)
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Analyst Views
7. Section
Research Methodology
About us

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us